Filana Therapeutics (FLNA)

• Market cap: $63.8M
• 1 day: -0.76%
• 5 days: -4.38%
• 1 month: 2.34%
• 3 months: -37.32%
• 6 months: -58.41%
• Year to date: -37.32%
• 1 year: -37.32%
• 5 years: -98.3%
• 10 years: -91.21%
• Sector: Healthcare
• Industry: Biotechnology

About: Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Employees: 20